Cytoreductive surgery in patients with advanced ovarian cancer: Surgical complexity score and postoperative complications
-
Published:2023-10-23
Issue:17
Volume:
Page:51-57
-
ISSN:2949-2807
-
Container-title:Medical alphabet
-
language:
-
Short-container-title:Medicinskij alfavit
Author:
Yakovleva M. G.1ORCID, Gorodnova T. V.1ORCID, Kotiv Kh. B.1ORCID, Smirnova O. A.1, Lavrinovich O. E.1ORCID, Mikaya N. A.1ORCID, Trifanov Yu. N.1, Guseynov K. D.1ORCID, Bakhidze E. V.2ORCID, Meshkova I. E.1, Nekrasova E. А.1, Shagal М. А.1, Тyatkov S. А.1, Okonechnikova D. V.1ORCID, Ulrich E. A.3ORCID, Urmancheeva A. F.2ORCID, Rostovcev D. M.4, Berlev I. V.2ORCID
Affiliation:
1. National Medical Research Centre of Oncology n. a. N. N. Petrov 2. National Medical Research Centre of Oncology n. a. N. N. Petrov; North-Western State Medical University n. a. I. I. Mechnikov 3. National Medical Research Centre of Oncology n. a. N. N. Petrov; North-Western State Medical University n. a. I. I. Mechnikov; National Medical Research Centre n. a. V. A. Almazov 4. Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
Abstract
Introduction. Cytoreductive surgery in patients with advanced ovarian cancer often involves extensive combined surgical interventions, which can affect the development of postoperative complications.Aim. To evaluate the results of surgical treatment in patients with advanced ovarian cancer.Methods. The study included 190 primary IIB–IV stage ovarian cancer patients who underwent surgical treatment in the oncogynecological department of the National Medical Research Centre of Oncology n. a. N. N. Petrov (Saint Petersburg, Russia) from August 2017 to August 2020. The dissemination in the peritoneum was assessed by calculating the peritoneal carcinomatosis index (PCI). Surgical complexity score was assessed using Aletti’s classification. Analysis of postoperative complications was carried out in accordance with the Clavien – Dindo classification.Results. The incidence of postoperative complications depended on the index of surgical complexity score (5 % – with a low index, 15 % – with median, 63 % – with a high one, p < 0.0010). In the group of primary cytoreductive surgeries, cases of median (48.9 %) and high complexity score (24.44 %) prevailed; in the group of interval debulking surgery, cases of low (52.4 %) and median (36.5 %) complexity score prevailed. The index of surgical complexity score depended on the peritoneal carcinomatosis index (PCI). The operation time, the volume of blood loss, the duration of hospitalization, frequency of bowel resection depended on the peritoneal carcinomatosis index and the surgical complexity score (p < 0.0001).Conclusions. The level of surgical complexity score in patients with advanced ovarian cancer depends on the peritoneal carcinomatosis index. The level of surgical complexity score is higher in the group of primary debulking surgery, which effect on frequency of postoperative complications.
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference17 articles.
1. Kotsopoulos J, Rosen B, Fan I, Moody J, McLaughlin JR, Risch H, May T, Sun P, Narod SA. Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status. Gynecol Oncol. 2016 Jan; 140 (1): 42–7. DOI: 10.1016/j.ygyno.2015.11.009. Epub 2015 Nov 7. PMID: 26556769. 2. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol. 2002 Mar 1; 20 (5): 1248–59. DOI: 10.1200/jco.2002.20.5.1248. PMID: 11870167. 3. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009 Mar 15; 115 (6): 1234–44. DOI: 10.1002/cncr.24149. PMID: 19189349. 4. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 1975 Oct; 42: 101–4. PMID: 1234624. 5. Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010 Sep 2; 363 (10): 943–53. DOI: 10.1056/nejmoa0908806. PMID: 20818904.
|
|